10x Genomics: Q2 Earnings Snapshot

August 8, 2022 GMT

PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Monday reported a loss of $64.5 million in its second quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 57 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.

The life science technology company posted revenue of $114.6 million in the period.

10x Genomics expects full-year revenue in the range of $500 million to $520 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG